Idexx Laboratories (IDXX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2013 | 12-2012 | 12-2011 | 12-2010 | 12-2009 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 187,794 | 178,287 | 161,754 | 141,320 | 122,235 |
| Depreciation Amortization | 54,596 | 52,408 | 48,202 | 45,956 | 49,773 |
| Income taxes - deferred | 2,073 | -1,970 | 5,996 | -908 | 3,270 |
| Accounts receivable | -15,946 | 3,487 | -24,809 | -6,914 | -1,155 |
| Accounts payable and accrued liabilities | -4,399 | -2,898 | 13,015 | 3,482 | -9,156 |
| Other Working Capital | -3,063 | -5,611 | 3,544 | -3,135 | -10,300 |
| Other Operating Activity | 24,941 | -1,295 | 10,211 | -968 | 20,285 |
| Operating Cash Flow | $245,996 | $222,408 | $217,913 | $178,833 | $174,952 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -77,612 | -57,573 | -49,452 | -38,796 | -48,584 |
| Net Acquisitions | -7,423 | 342 | -43,757 | N/A | -4,537 |
| Purchase Of Investment | N/A | N/A | N/A | -4,000 | 0 |
| Purchase Sale Intangibles | -1,024 | -900 | -1,000 | -394 | -500 |
| Other Investing Activity | -1,024 | -900 | -1,000 | -394 | -500 |
| Investing Cash Flow | $-86,059 | $-58,131 | $-94,209 | $-43,190 | $-53,621 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | 65,000 | -31,000 | 113,903 | 10,143 | -32,830 |
| Debt Issued | 150,000 | N/A | N/A | N/A | N/A |
| Common Stock Issued | 38,235 | 24,166 | 28,801 | 28,865 | 16,366 |
| Common Stock Repurchased | -367,761 | -132,268 | -255,505 | -143,090 | -83,099 |
| Other Financing Activity | 12,075 | 13,759 | 15,144 | 17,313 | 4,268 |
| Financing Cash Flow | $-102,451 | $-125,343 | $-97,657 | $-86,769 | $-95,295 |
| Exchange Rate Effect | -2,414 | 1,157 | 933 | 1,313 | 1,824 |
| Beginning Cash Position | 223,986 | 183,895 | 156,915 | 106,728 | 78,868 |
| End Cash Position | 279,058 | 223,986 | 183,895 | 156,915 | 106,728 |
| Net Cash Flow | $55,072 | $40,091 | $26,980 | $50,187 | $27,860 |
| Free Cash Flow | |||||
| Operating Cash Flow | 245,996 | 222,408 | 217,913 | 178,833 | 174,952 |
| Capital Expenditure | -77,612 | -57,618 | -49,677 | -38,908 | -50,663 |
| Free Cash Flow | 168,384 | 164,790 | 168,236 | 139,925 | 124,289 |